» Authors » Aykut Demirkiran

Aykut Demirkiran

Explore the profile of Aykut Demirkiran including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aydin C, Orta H, Engin M, Demirkiran A
Angiology . 2025 Mar; :33197251326385. PMID: 40037330
No abstract available.
2.
Demirkiran A, Aydin C, Akyuz A, Alpsoy S
Turk Kardiyol Dern Ars . 2025 Mar; 53(2):93-99. PMID: 40035253
Objective: There remain conflicting recommendations regarding revascularization strategies for patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease (MVD). This study aimed to compare the long-term outcomes of different...
3.
4.
Demirkiran A, Aydin C, Orta H
Angiology . 2025 Feb; :33197251321263. PMID: 39950213
No abstract available.
5.
6.
Kocak M, Araz M, Findik S, Demirkiran A, Korkmaz M, Karakurt Eryilmaz M, et al.
Biomol Biomed . 2025 Jan; PMID: 39869369
The cysteine-rich epidermal growth factor ligand domain 2 protein (CRELD2) is associated with pathways that regulate epithelial-to-mesenchymal transition, a critical process driving cancer metastasis. This study aimed to determine the...
7.
Aykac H, Aydin C, Demirkiran A, Uslu N, Alpsoy S
Kardiologiia . 2024 Sep; 64(8):56-63. PMID: 39262354
Aim: Atrial fibrillation (AF) is a rhythm disorder characterized by very rapid and disorganized atrial-derived electrical activations with uncoordinated atrial contractions. Very short periods of AF-like activity (micro-AF) may be...
8.
Demirkiran A, Aydin C, Orun S, Kaplangoray M
Rev Assoc Med Bras (1992) . 2024 Sep; 70(8):e20240647. PMID: 39230152
Objective: Sudden cardiac death or arrest describes an unexpected cardiac cause-related death or arrest that occurs rapidly out of the hospital or in the emergency room. This study aimed to...
9.
Efe M, Akyuz A, Aydin C, Demirkiran A, Alpsoy S
Rev Assoc Med Bras (1992) . 2024 Sep; 70(8):e20240515. PMID: 39230149
Objective: Coronary artery disease (CAD) is frequent, but coronary slow flow (CSF) is a less common cardiovascular disease with a significant risk of mortality and morbidity. Endocan is a proinflammatory...
10.
Araz M, Beypinar I, Inci F, Koral L, Kocak M, Korkmaz M, et al.
J Oncol Pharm Pract . 2024 Aug; :10781552241279537. PMID: 39196659
Introduction: We compared the efficacy of first-generation granisetron and second-generation palonosetron in triplet anti-emetic prophylaxis in patients with non-small cell lung cancer (NSCLC) receiving cisplatin-based high emetogenic chemotherapy (HEC). Methods:...